Skip to main content

Advertisement

Log in

Successful transplantation of ethnically mismatched cord blood in a boy with atypical chronic myeloid leukemia

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

In the present study, we describe unrelated umbilical cord blood transplantation (CBT) in a 7-year-old Taiwanese boy with atypical chronic myeloid leukemia (BCR-ABL 1 negative). Physical examination was notable for splenomegaly. Cytogenetic analyses from the bone marrow revealed a t(3;5)(p21;q31) translocation. The patient then underwent CBT from an HLA-mismatched (two loci by serotype, three loci by genotype) unrelated donor of Caucasian origin. Times to neutrophil and platelet engraftment were 21 and 62 days post-transplant, respectively. Acute graft-versus-host disease following transplantation was minimal. The patient remains in continuing hematological remission with full donor chimerism 28 months after transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Ballen KK, Klein JP, Pedersen TL, Bhatla D, Duerst R, Kurtzberg J, et al. Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes. Biol Blood Marrow Transplant. 2012;18:903–12.

    Article  PubMed  Google Scholar 

  2. Vardiman J, Hyjek E. Evaluation, classification and genetics in the diagnosis of myeloproliferative neoplasm (MPN) variants. Hematol Am Soc Hematol Educ Program. 2011;2011:250–6.

    Article  Google Scholar 

  3. Reiter A, Invernizzi R, Cross NC, Cazzola M. Molecular basis of myelodysplastic/myeloproliferative neoplasms. Haematologica. 2009;94:1634–8.

    Article  PubMed  CAS  Google Scholar 

  4. Cazzola M, Malcovati L, Invernizzi R. Myelodysplastic/myeloproliferative neoplasms. Hematol Am Soc Hematol Educ Program. 2011;2011:264–72.

    Article  Google Scholar 

  5. Koldehoff M, Beelen DW, Trenschel R, Steckel NK, Peceny R, Ditschkowski M, et al. Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia. Bone Marrow Transplant. 2004;34:1047–50.

    Article  PubMed  CAS  Google Scholar 

  6. Koldehoff M, Steckel NK, Hegerfeldt Y, Ditschkowski M, Beelen DW, Elmaagacli AH. Clinical course and molecular features in 21 patients with atypical chronic myeloid leukemia. Int J Lab Hematol. 2012;34:e3–5.

    Article  PubMed  CAS  Google Scholar 

  7. Molldrem J, Riddell S. Understanding and enhancing the graft-versus-leukemia effect after hematopoietic stem cell transplantation. Cancer Treat Res. 2009;144:187–208.

    Article  PubMed  CAS  Google Scholar 

  8. Riddell SR, Bleakley M, Nishida T, Berger C, Warren EH. Adoptive transfer of allogeneic antigen-specific T cells. Biol Blood Marrow Transplant. 2006;12(1 Suppl 1):9–12.

    Article  PubMed  CAS  Google Scholar 

  9. Ruggeri L, Mancusi A, Burchielli E, Aversa F, Martelli MF, Velardi A. Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. Curr Opin Oncol. 2007;19:142–7.

    Article  PubMed  Google Scholar 

  10. Cortes J, Talpaz M, Beran M, O’Brien SM, Rios MB, Stass S, Kantarjian HM. Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Cancer. 1995;75:464–70.

    Article  PubMed  CAS  Google Scholar 

  11. Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007;369:1947–54.

    Article  PubMed  Google Scholar 

  12. Goldman JM, Green AR, Holyoake T, Jamieson C, Mesa R, Mughal T, et al. Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues. Leukemia. 2009;23:1708–15.

    Article  PubMed  CAS  Google Scholar 

  13. Bock O, Hussein K, Kreipe H. Stem cell defects in Philadelphia chromosome negative chronic myeloproliferative disorders: a phenotypic and molecular puzzle? Curr Stem Cell Res Ther. 2007;2:253–63.

    Article  PubMed  CAS  Google Scholar 

  14. Sanz J, Montesinos P, Saavedra S, Lorenzo I, Senent L, Planelles D, et al. Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia. Biol Blood Marrow Transplant. 2010;16:1589–95.

    Article  PubMed  Google Scholar 

  15. Suttorp M, Millot F. Treatment of pediatric chronic myeloid leukemia in the year, use of tyrosine kinase inhibitors and stem-cell transplantation. Hematology. 2010;2010:368–76.

    Article  PubMed  Google Scholar 

  16. Baxter EJ, Kulkarni S, Vizmanos JL, Jaju R, Martinelli G, Testoni N, et al. Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders. Br J Haematol. 2003;120:251–6.

    Article  PubMed  CAS  Google Scholar 

  17. Goi K, Inukai T, Honna H, Akahane K, Akahane K, Hirose K, et al. Successful tandem (autologous-cord blood) SCT in advanced neuroblastomas with highly amplified MYCN. Bone Marrow Transplant. 2011;46:835–9.

    Article  PubMed  CAS  Google Scholar 

  18. Talmadge JE. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Int Immunopharmacol. 2003;3:1121–43.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the research grand CMRPG4A0031 from Chang Gung Memorial Hospital.

Conflict of interest

The authors have no conflicts of interests or funding to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tang-Her Jaing.

About this article

Cite this article

Jaing, TH., Hung, IJ., Chen, SH. et al. Successful transplantation of ethnically mismatched cord blood in a boy with atypical chronic myeloid leukemia. Int J Hematol 97, 144–146 (2013). https://doi.org/10.1007/s12185-012-1251-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-012-1251-2

Keywords

Navigation